IKEM Klinika nefrologie
Prague 140 21
0 studies enrolling now · 2 studies all time
What they study most
Cardiovascular Risk, Chronic Kidney Disease, Inflammation
Studies at this site
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — Recruiting now
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed